UBS Maintains Neutral on Xylem, Raises Price Target to $135
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $129 to $135.
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $129 to $135.